BioSpace News Archive

Boston-based health technology company moves to new office location to accommodate rapid growth

Join more than 2,600 healthcare compliance professionals in Boston, April 7-10, 2019 for the 23rd Annual Compliance Institute, hosted by the Health Care Compliance Association (HCCA).

Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will conduct a CME-accredited satellite symposium, Optimizing Care in the Era of an Expanding Armamentarium for Hepatocellular Carcinoma, adjunct to the 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium.

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the much-anticipated full launch of its Simoa SP-X Imaging and Detection System, 10-Plex Simoa CorPlex Cytokine Panel, and broad menu of additional multiplex panels.

The Vitamin Shoppe® (NYSE: VSI), an omni-channel specialty retailer of nutritional products, has welcomed Kris Gethin to its Wellness Council

Data shows statistically significant improvement after 3 months of treatment in both objective and subjective measures [10-January-2019] HOD HASHARON, Israel, Jan. 10, 2019 /PRNewswire/ -- Wize Pharma, Inc. (“Wize Pharma” or the “Company”) (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today annou

Hydrofarm Holdings Group, Inc., a leading independent wholesaler and manufacturer of hydroponics equipment and commercial horticultural products, today announced a strategic partnership with Argus Control Systems Ltd. to provide advanced environmental systems and services for horticultural production in the United States and Canada.

Two of Philadelphia’s leading academic and healthcare organizations have signed an agreement that creates an exclusive 90-day window within which to consider and negotiate the acquisition and conduct due diligence by Jefferson of the Fox Chase Cancer Center.

Blue Mesa Health Inc. (“Blue Mesa”), a global digital therapeutics company with headquarters in New York, Vancouver, São Paulo and Dubai, announced today that its Diabetes Prevention Program (DPP) “Transform” will be available in Chinese, Portuguese and Arabic translations in California and worldwide starting Q2 2019.

Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY), a global leader in cannabis production and distribution, today announced that Brendan Kennedy, President and Chief Executive Officer, and Mark Castaneda, Chief Financial Officer, Secretary and Treasurer, will present at the 2019 ICR Conference.